JAK2 and neoplasm: In prostate cancer lacking PTEN, activated JAK2/STAT3 signaling established an immunosuppressive tumor microenvironment via SASP factors such as CXCL1, CXCL2, and IL-6 and resulted in tumor growth and chemoresistance [49].